High frequency of rejections in HIV-positive recipients of kidney transplantation: A single center prospective trial

Transplantation

Volumn 94, Issue 10, 2012, Pages 1020-1024

  Malat, Gregory E ^a   Ranganna, Karthik M ^a   Sikalas, Nicholas ^a   Liu, Longjin ^b   Jindal, Rahul M ^c,d   Doyle, Alden ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b DREXEL UNIVERSITY   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

Allograft survival; Antibody mediated rejection; HIV; Kidney transplantation

Indexed keywords

ANTIRETROVIRUS AGENT; BASILIXIMAB; CREATININE; CYCLOSPORIN; MYCOPHENOLIC ACID; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RAPAMYCIN; RITUXIMAB; STEROID; THYMOCYTE ANTIBODY;

ACUTE ANTIBODY MEDIATED REJECTION; ACUTE GRAFT REJECTION; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INCIDENCE; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL TIME;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; CREATININE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TISSUE DONORS;

EID: 84870190336     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31826c3947     Document Type: Article

References (14)

1. Stock PG, Barin B, Murphy B, et al. Outcomes of kidney transplantation in HIV-infected recipients. N Eng J Med 2010; 363: 2004.
2. Touzot M, Pillebout E, Matignon M, et al. Renal transplantation in HIV-infected patients: the Paris experience. Am J Transplant 2010; 10: 2263.
3. Qiu J, Terasaki PI, Waki K, et al. HIV-positive renal recipients can achieve survival rates similar to those of HIV-negative recipients. Transplantation 2006; 81: 1658.
4. Kumar MSA, Sierka DR, Damask AM, et al. Safety and success of kidney transplantation and concomitant immunosuppression in HIVpositive patients. Kidney Int 2005; 67: 1622.
5. Carter JT, Melcher ML, Carlson LL, et al. Thymoglobulin-associated CD4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients. Am J Transplant 2006; 6: 753.
6. Roland ME, Barin B, Carlson L, et al. HIV-Infected liver and kidney transplant recipients: 1-and 3-year outcomes. Am J Transplant 2008; 8: 355.
7. Coopman SA, Johnson RA, Platt R, et al. Cutaneous disease and drug reactions in HIV Infection. N Eng J Med 1993; 328: 1670.
8. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247.
9. Kumar MSA, Saeed MI, Ranganna K, et al. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. Transpl Immunol 2008; 20: 32.
10. Takemoto SK, Zeevi A, Feng S, et al. National Conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004; 4: 1033.
11. Locke JE, Montgomery RA, Warren DS, et al. Renal transplant in HIV-positive patients: long-term outcomes and risk factors for graft loss. Arch Surg 2009; 144: 83.
12. Gasser O, Bihl F, Sanghavi S, et al. Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with Herpes virus reactivation. Am J Transplant 2009; 9: 794.
13. Frassetto L, Baluom M, Jacobsen W, et al. Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virusinfected liver and kidney transplant recipients. Transplantation 2005; 80: 13.
14. Solez K, Colvin RB, Racusen LC, et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7: 518.